References

  1. Taghi NF, Batul SM, Masoud S, Mohammad N, Narges S, Neda N. Prévalence of non tuberculous mycobacteria in southeast Iran. J Med Sci. 2006; 6(2):292-5. PubMed | Google Scholar

  2. Glassroth J. Pulmonary disease due to non tuberculous mycobactéria. Chest. 20O8; 133: 243-251. PubMed | Google Scholar

  3. Pineda-Garcia L, Ferrera A, Galvez CA, Hoffnercoll SE. Drug-Resistant Mycobacterium tuberculosis and Atypical Mycobacteria Isolated from Patients with Suspected Pulmonary Tuberculosis in Honduras. Chest. 1997;111:148-15. PubMed | Google Scholar

  4. Corbett EL, Blumberg L, De Cock KM. Non tuberculous mycobacteria, defining disease in a prospective cohort of South African miners. Am J Respir Crit Care Med. 1999; 160: 15-21. PubMed | Google Scholar

  5. Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med. 2002; 23(3):553-67. PubMed | Google Scholar

  6. Cahier de formation. Biologie médicale : Mycobactéries et mycobactérioses. 2003 ; numéro 23 : 158p. Google Scholar

  7. Van Crevel R, de Lange WC, Vanderpuye NA, Van Soolingen D, Hoogkamp-Korstanje JAA, Van Deuren M, et al. The impact of nontuberculous mycobacteria on management of presumed pulmonary tuberculosis. Infection. 2001; 29(2):59-63. PubMed | Google Scholar

  8. Koh WJ, Kwon OJ, Lee KS. Nontuberculous mycobacterial pulmonary diseases in immunocompetent patients. Korean J Radiol. 2002; 3:145-57. PubMed | Google Scholar

  9. PNT. Guide technique de lutte antituberculeuse, Burkina Faso. Ed 2011 ; page 144. Google Scholar

  10. Ouédraogo M, Ouédraogo SM, Digbouga S, Zoubga ZA. Infection mycobactérienne et sérologie VIH au Burkina Faso. Médecine d'Afrique noire. 2001 ; 48(8/9) : 368-70. PubMed | Google Scholar

  11. Casabona NM, Bahrmand AR, Bennedsen J, Ostergaard Thomsen V, Curcio M, Fauville-Dufaux M, et al. Non tuberculous mycobacteria: patterns of isolation, A multi country retrospective survey. Int J Tuberc Lung Dis. 2004; 8(10): 1186-93. PubMed | Google Scholar

  12. Miotto P, Saleri N, Dembélé M, Ouedraogo M, Badoum G, Pinsi G, et al. Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso. BMC Infectious Diseases. 2009; 9(142): 1-8. PubMed | Google Scholar

  13. Buijtels PCAM, Van der Sande MAB, De Graaff CS, Parkinson S, Verbrugh HA, Petit PLC, et al. Nontuberculous Mycobacteria, Zambia. Emerging Infectious Diseases. 2009; 15(2): 242-49. PubMed | Google Scholar

  14. Gerogiani I, Papala M, Gourgoulianis KI. Epidemiology and clinical significance of mycobacterial respiratory infections in central Greece. Int J Tuberc Lung Dis. 2008; 12(7): 808-12. PubMed | Google Scholar

  15. Wallace RJ, O'Brien R, Glassroth J. American thoracic society: Diagnostic and treatment of diseases caused by non tuberculous mycobacteria. Am J Respir Crit Care Med. 1997; 156: S1-S25. PubMed | Google Scholar